IMA Clinical Research
Mark I. Weinberger, PhD, MPH is the President and CEO of The IMA Group, a position held since July 2011. Under Weinberger's leadership, the organization has focused on improving the quality of life for individuals facing health and disability challenges while contributing to medical advancements across a nationwide network. Concurrently, Weinberger serves as President and CEO of IMA Clinical Research, which aims to facilitate the development of new medical treatments through an extensive clinical trial network. Previous academic roles include Instructor of Psychology in Psychiatry and Post Doctoral Research Fellow at Weill Cornell Medical College. Weinberger's educational background includes a PhD and MS in Clinical Psychology from the University of Massachusetts Amherst, an MPH in Epidemiology from New York Medical College, and various certificates in finance and management from prestigious institutions such as Harvard Business School Online and The London School of Economics.
This person is not in any offices
IMA Clinical Research
1 followers
Our clinical research network is a collaborative group of providers and sites dedicated to clinical research across multiple therapeutic areas. When sponsors and CROs join our nationwide network, they immediately gain access to diverse patient populations in both cities and underserved locations and the innovative tools needed to accelerate enrollment, support patients during trials, improve retention, and enhance data and understanding. Additionally, we use a modern, tech-enabled operating model to deliver various study designs, including classic site-based, hybrid and fully decentralized trials. The IMA Clinical Research Network: • 20+ Full-Service Clinical Trial Sites • 180+ Nationwide Satellite Sites • 10K+ Unique Weekly Visits • 400K+ Patient Database To learn more about IMA Clinical Research, visit imaresearch.com